FDA approves standalone use of J&J's ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...
MarketWatch20h
E-Mini S&P 500 Future Continuous Contract
2-Year U.S. Treasury Note Continuous Contract $102.754 0.020 0.02% 5-Year U.S. Treasury Note Continuous Contract $106.273 0.109 0.10% 10-Year U.S. Treasury Note Continuous Contract $108.781 0.234 ...
Indiatimes9h
Nifty 500
What does Nifty 500 represent? Nifty 500 represents a broad market index comprising 500 large-cap, mid-cap, and small-cap stocks listed on the National Stock Exchange (NSE), offering diversified ...
medtechdive11h
Irish Neurotech Start-up, CergenX Receives FDA Breakthrough Designation for Wave Device
A CergenX-led consortium, including UCC/ INFANT, was awarded €6.7 million in funding from The Disruptive Technologies Innovation Fund (DTIF), to develop CergenX Wave, an automated AI assessment to ...